Galena Biopharma (GALE) Reports Q3 Loss of $0.02/Share

November 9, 2016 5:14 PM EST
Get Alerts GALE Hot Sheet
Trade GALE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

Galena Biopharma (NASDAQ: GALE) reported Q3 EPS of ($0.02), versus ($0.04) reported last year.

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment